Technische Universität München
Stories about Elevation
- more
Merck to Showcase New Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting, Furthering Innovation in Multiple Sclerosis
moreBAT Named in The Gartner Supply Chain Top 25 for 2020
moreAbstracts highlight data on BAVENCIO as a monotherapy and in combination in multiple advanced cancers
moreNew Data at ESMO 2019 for Merck Highlight Focused Clinical Development and Commitment to Patient Care
moreCHMP Adopts Positive Opinion for BAVENCIO® (avelumab) Plus Axitinib for First-Line Treatment of Patients with Advanced Renal Cell Carcinoma
moreMerck to Showcase New Data Across MS Portfolio at EAN 2019
moreMerck to Present New Data on Mavenclad®, Rebif® and the Investigational Therapy Evobrutinib at the AAN Annual Meeting 2019
morePosterior and Right Ventricular Myocardial Infarction Detection - CardioSecur® Shines a Light on the Dark Side of the Moon
2 DocumentsmorePivotal Phase III Data for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) in Advanced Renal Cell Carcinoma Published in the New England Journal of Medicine
moreFDA Accepts sBLA and Grants Priority Review for BAVENCIO® (avelumab) Plus INLYTA® (axitinib) for the Treatment of Advanced Renal Cell Carcinoma
more
1